Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
Recruiting · NCT02744365 · Observational (researchers observe without assigning treatment) · Lead sponsor: CHU de Quebec-Universite Laval
View the official record on ClinicalTrials.gov →Interventions studied
Observational
What this trial is about
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- (specific to each study)
Exclusion criteria
- pregnant women \<18 years old at recruitment
- negative fetal heart at recruitment
- women not able to provide an informed consent to the study
Where it is running
1 location listed.
- CHU de Quebec - Québec, Canada